Presented by Steven A. Julious Steven is a Professor of Medical Statistics at The University of Sheffield but through his career has worked in both the academic and pharmaceutical sector and is a former editor of the journal Pharmaceutical Statistics. He has an interest in applied methods for clinical trials and has a particular interest in clinical study design and sample size estimation. He has written two books one on early phase trials and one on sample size estimation and has also developed an App called SampSize for the estimation of sample sizes.
About the course: The three most important aspects of a clinical trial are: design, design and design. A sample size estimate is just one aspect of a clinical study design.
The course describes calculations for sample size estimation in the design of clinical trials. It will be highlighted how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.
The following topics will be covered:
Introduction to Key Concepts
- Type I error
- Type II error
- Power
Sample Sizes for Different Clinical Trial Objectives - Superiority
- Equivalence
- Non-inferiority
- Precision based
- Bioequivalence
- Pilot studies
Sample Sizes for Different Types of Data - Normal
- Binary
- Ordinal
- Survival
Clinical Trial Designs - Cross-over
- Parallel Group
How Design Considerations Impact on the Sample Size - Baselines/covariates
- Multiple endpoints
Other Considerations when Designing a Trial - Sensitivity analysis
- Optimising variance estimates
Considerations which Impact on the Sample Size - Adaptive designs for efficacy
- Assessing futility
- Sample size-re-estimation
Course runs from:
10:00 – 17:30 (registration from 9:30) on Day 1
09:00 – 16:30 on Day 2.
Registration costs (includes lunch and refreshments)
Before 30th May 2017
PSI Members
£495 + VAT
Non-Members
£570 + VAT (includes PSI membership for 1 year)
After 30th May 2017
PSI Members
£595 + VAT
Non-Members
£670 + VAT (includes PSI membership for 1 year)
PSI are holding a limited number of hotel rooms at an extra cost until the 30th May 2017 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Presented by Steven A. Julious Steven is a Professor of Medical Statistics at The University of Sheffield but through his career has worked in both the academic and pharmaceutical sector and is a former editor of the journal Pharmaceutical Statistics. He has an interest in applied methods for clinical trials and has a particular interest in clinical study design and sample size estimation. He has written two books one on early phase trials and one on sample size estimation and has also developed an App called SampSize for the estimation of sample sizes.
About the course: The three most important aspects of a clinical trial are: design, design and design. A sample size estimate is just one aspect of a clinical study design.
The course describes calculations for sample size estimation in the design of clinical trials. It will be highlighted how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.
The following topics will be covered:
Introduction to Key Concepts
- Type I error
- Type II error
- Power
Sample Sizes for Different Clinical Trial Objectives - Superiority
- Equivalence
- Non-inferiority
- Precision based
- Bioequivalence
- Pilot studies
Sample Sizes for Different Types of Data - Normal
- Binary
- Ordinal
- Survival
Clinical Trial Designs - Cross-over
- Parallel Group
How Design Considerations Impact on the Sample Size - Baselines/covariates
- Multiple endpoints
Other Considerations when Designing a Trial - Sensitivity analysis
- Optimising variance estimates
Considerations which Impact on the Sample Size - Adaptive designs for efficacy
- Assessing futility
- Sample size-re-estimation
Course runs from:
10:00 – 17:30 (registration from 9:30) on Day 1
09:00 – 16:30 on Day 2.
Registration costs (includes lunch and refreshments)
Before 30th May 2017
PSI Members
£495 + VAT
Non-Members
£570 + VAT (includes PSI membership for 1 year)
After 30th May 2017
PSI Members
£595 + VAT
Non-Members
£670 + VAT (includes PSI membership for 1 year)
PSI are holding a limited number of hotel rooms at an extra cost until the 30th May 2017 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Presented by Steven A. Julious Steven is a Professor of Medical Statistics at The University of Sheffield but through his career has worked in both the academic and pharmaceutical sector and is a former editor of the journal Pharmaceutical Statistics. He has an interest in applied methods for clinical trials and has a particular interest in clinical study design and sample size estimation. He has written two books one on early phase trials and one on sample size estimation and has also developed an App called SampSize for the estimation of sample sizes.
About the course: The three most important aspects of a clinical trial are: design, design and design. A sample size estimate is just one aspect of a clinical study design.
The course describes calculations for sample size estimation in the design of clinical trials. It will be highlighted how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.
The following topics will be covered:
Introduction to Key Concepts
- Type I error
- Type II error
- Power
Sample Sizes for Different Clinical Trial Objectives - Superiority
- Equivalence
- Non-inferiority
- Precision based
- Bioequivalence
- Pilot studies
Sample Sizes for Different Types of Data - Normal
- Binary
- Ordinal
- Survival
Clinical Trial Designs - Cross-over
- Parallel Group
How Design Considerations Impact on the Sample Size - Baselines/covariates
- Multiple endpoints
Other Considerations when Designing a Trial - Sensitivity analysis
- Optimising variance estimates
Considerations which Impact on the Sample Size - Adaptive designs for efficacy
- Assessing futility
- Sample size-re-estimation
Course runs from:
10:00 – 17:30 (registration from 9:30) on Day 1
09:00 – 16:30 on Day 2.
Registration costs (includes lunch and refreshments)
Before 30th May 2017
PSI Members
£495 + VAT
Non-Members
£570 + VAT (includes PSI membership for 1 year)
After 30th May 2017
PSI Members
£595 + VAT
Non-Members
£670 + VAT (includes PSI membership for 1 year)
PSI are holding a limited number of hotel rooms at an extra cost until the 30th May 2017 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Presented by Steven A. Julious Steven is a Professor of Medical Statistics at The University of Sheffield but through his career has worked in both the academic and pharmaceutical sector and is a former editor of the journal Pharmaceutical Statistics. He has an interest in applied methods for clinical trials and has a particular interest in clinical study design and sample size estimation. He has written two books one on early phase trials and one on sample size estimation and has also developed an App called SampSize for the estimation of sample sizes.
About the course: The three most important aspects of a clinical trial are: design, design and design. A sample size estimate is just one aspect of a clinical study design.
The course describes calculations for sample size estimation in the design of clinical trials. It will be highlighted how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.
The following topics will be covered:
Introduction to Key Concepts
- Type I error
- Type II error
- Power
Sample Sizes for Different Clinical Trial Objectives - Superiority
- Equivalence
- Non-inferiority
- Precision based
- Bioequivalence
- Pilot studies
Sample Sizes for Different Types of Data - Normal
- Binary
- Ordinal
- Survival
Clinical Trial Designs - Cross-over
- Parallel Group
How Design Considerations Impact on the Sample Size - Baselines/covariates
- Multiple endpoints
Other Considerations when Designing a Trial - Sensitivity analysis
- Optimising variance estimates
Considerations which Impact on the Sample Size - Adaptive designs for efficacy
- Assessing futility
- Sample size-re-estimation
Course runs from:
10:00 – 17:30 (registration from 9:30) on Day 1
09:00 – 16:30 on Day 2.
Registration costs (includes lunch and refreshments)
Before 30th May 2017
PSI Members
£495 + VAT
Non-Members
£570 + VAT (includes PSI membership for 1 year)
After 30th May 2017
PSI Members
£595 + VAT
Non-Members
£670 + VAT (includes PSI membership for 1 year)
PSI are holding a limited number of hotel rooms at an extra cost until the 30th May 2017 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Presented by Steven A. Julious Steven is a Professor of Medical Statistics at The University of Sheffield but through his career has worked in both the academic and pharmaceutical sector and is a former editor of the journal Pharmaceutical Statistics. He has an interest in applied methods for clinical trials and has a particular interest in clinical study design and sample size estimation. He has written two books one on early phase trials and one on sample size estimation and has also developed an App called SampSize for the estimation of sample sizes.
About the course: The three most important aspects of a clinical trial are: design, design and design. A sample size estimate is just one aspect of a clinical study design.
The course describes calculations for sample size estimation in the design of clinical trials. It will be highlighted how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.
The following topics will be covered:
Introduction to Key Concepts
- Type I error
- Type II error
- Power
Sample Sizes for Different Clinical Trial Objectives - Superiority
- Equivalence
- Non-inferiority
- Precision based
- Bioequivalence
- Pilot studies
Sample Sizes for Different Types of Data - Normal
- Binary
- Ordinal
- Survival
Clinical Trial Designs - Cross-over
- Parallel Group
How Design Considerations Impact on the Sample Size - Baselines/covariates
- Multiple endpoints
Other Considerations when Designing a Trial - Sensitivity analysis
- Optimising variance estimates
Considerations which Impact on the Sample Size - Adaptive designs for efficacy
- Assessing futility
- Sample size-re-estimation
Course runs from:
10:00 – 17:30 (registration from 9:30) on Day 1
09:00 – 16:30 on Day 2.
Registration costs (includes lunch and refreshments)
Before 30th May 2017
PSI Members
£495 + VAT
Non-Members
£570 + VAT (includes PSI membership for 1 year)
After 30th May 2017
PSI Members
£595 + VAT
Non-Members
£670 + VAT (includes PSI membership for 1 year)
PSI are holding a limited number of hotel rooms at an extra cost until the 30th May 2017 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Presented by Steven A. Julious Steven is a Professor of Medical Statistics at The University of Sheffield but through his career has worked in both the academic and pharmaceutical sector and is a former editor of the journal Pharmaceutical Statistics. He has an interest in applied methods for clinical trials and has a particular interest in clinical study design and sample size estimation. He has written two books one on early phase trials and one on sample size estimation and has also developed an App called SampSize for the estimation of sample sizes.
About the course: The three most important aspects of a clinical trial are: design, design and design. A sample size estimate is just one aspect of a clinical study design.
The course describes calculations for sample size estimation in the design of clinical trials. It will be highlighted how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.
The following topics will be covered:
Introduction to Key Concepts
- Type I error
- Type II error
- Power
Sample Sizes for Different Clinical Trial Objectives - Superiority
- Equivalence
- Non-inferiority
- Precision based
- Bioequivalence
- Pilot studies
Sample Sizes for Different Types of Data - Normal
- Binary
- Ordinal
- Survival
Clinical Trial Designs - Cross-over
- Parallel Group
How Design Considerations Impact on the Sample Size - Baselines/covariates
- Multiple endpoints
Other Considerations when Designing a Trial - Sensitivity analysis
- Optimising variance estimates
Considerations which Impact on the Sample Size - Adaptive designs for efficacy
- Assessing futility
- Sample size-re-estimation
Course runs from:
10:00 – 17:30 (registration from 9:30) on Day 1
09:00 – 16:30 on Day 2.
Registration costs (includes lunch and refreshments)
Before 30th May 2017
PSI Members
£495 + VAT
Non-Members
£570 + VAT (includes PSI membership for 1 year)
After 30th May 2017
PSI Members
£595 + VAT
Non-Members
£670 + VAT (includes PSI membership for 1 year)
PSI are holding a limited number of hotel rooms at an extra cost until the 30th May 2017 which will be allocated on a first come first served basis. Please contact the PSI Secretariat for more information.
Registration for this course has now closed.
Upcoming Events
PSI Training Course: Effective Leadership – the keys to growing your leadership capabilities
This course will consist of three online half-day workshops. The first will be aimed at building trust, the backbone of leadership and a key to becoming effective. This is key to building a solid foundation.
The second will be on improving communication as a technical leader. This workshop will focus on communication strategies for different stakeholders and will involve tips on effective communication and how to develop the skills of active listening, coaching and what improv can teach us about good communication.
The final workshop will bring these two components together to help leaders become more influential. This will also focus on how to use Steven Covey’s 7-Habits, in particular Habits 4, 5 and 6, which are called the habits of communication.
The workshops will be interactive, allowing you to practice the concepts discussed. There will be plenty of time for questions and discussion. There will also be reflective time where you can think about what you are learning and how you might experiment with it.
PSI Introduction to Industry Training (ITIT) Course - 2026/2027
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This webinar brings together three bitesize complementary sessions to help PSI contributors create conference presentations and posters that communicate clearly and inclusively. Participants will explore how to refine their message, prepare materials effectively, and adopt practical habits that support confident, accessible delivery. A focused, supportive session designed to elevate every contribution.
Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “Graphics Basics,” will introduce the fundamentals of producing graphics using the ggplot2 package.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Join our Health Technology Assessment (HTA) European Special Interest Group (ESIG) for a webinar on the strategic role of statisticians in the Joint Clinical Assessment (JCA). The introduction of the JCA marks a new era for evidence generation and market access in Europe. As HTA requirements become more harmonized and methodologically demanding, the role of statisticians has evolved far beyond data analysis. Today, statistical expertise is central to shaping clinical development strategies, designing robust comparative evidence, and ensuring that submissions withstand the scrutiny of EU-level assessors. In this webinar, we explore how statisticians contribute strategically to successful JCA outcomes.
Statisticians in the Age of AI: On Route to Strategic Partnership
A 90-minute webinar featuring two case studies from Bayer and Roche demonstrating how statisticians successfully integrated into AI programs, followed by interactive discussion on strategies for elevating statistical expertise in the AI era.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
GSK - Statistics Director - Vaccines and Infectious Disease
We are seeking an experienced and visionary Statistics Director to join our Team and lead strategic statistical innovation across GSK’s Vaccines and Infectious Disease portfolio.
As a Senior Biostatistician I at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.
As a Statistical Scientist at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.
We are currently looking for a Postdoctoral Research Fellow, Statistics (full-time, 3-year fixed-term) to join the team based in our office in London, United Kingdom.
We have an exciting opportunity for an Associate Director, Biostatistics to join a passionate team within Advanced Quantitative Sciences – Full Development.
We are looking for Senior Statistical Programmers in the UK to join Veramed, where you'll deliver high-impact programming solutions in an FSP-style capacity, while advancing your career in a supportive, growth-driven environment.
